Posted by Michael Wonder on 24 Oct 2021
Breast cancer treatment expanded on the Pharmaceutical Benefits Scheme
24 October 2021 - The Morrison Government is helping improve access to an important treatment for Australians battling a form of breast cancer.
From 1 November 2021, the Pharmaceutical Benefits Scheme listing of Verzenio (abemaciclib) will also be expanded for use in combination with fulvestrant.
